Levoleucovorin Calcium

  • # LGM Pharma is a Levoleucovorin Calcium CAS# 80433-71-2 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Levoleucovorin Calcium
  • CAS #: 80433-71-2
  • Toxicity:

    Mouse(iv): LD50 732 mg/kg

  • IUPAC: calcium;(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate
  • PubChem: 135500522
  • Formula: C20H21CaN7O7
  • Molecular Mass: 511.112837 g/mol
  • Synonyms: 5 Formyltetrahydrofolate, 5 Formyltetrahydropteroylglutamate, 5-Formyltetrahydrofolate, 5-Formyltetrahydropteroylglutamate, Acid, Folinic, Calcium Folinate, Calcium Leucovorin, Citrovorum Factor, Factor, Citrovorum, Folinate, Calcium, Folinic Acid, Folinic Acid SF, Folinic Acid-SF, Leucovorin, Leucovorin, (D)-Isomer, Leucovorin, (DL)-Isomer, Leucovorin, (R)-Isomer, Leucovorin, Calcium, Leucovorin, Calcium (1:1) Salt, Leucovorin, Calcium (1:1) Salt, (DL)-Isomer, Leucovorin, Calcium (1:1) Salt, Pentahydrate, Leucovorin, Monosodium Salt, Leukovorin, Leukovorum, Monosodium Salt Leucovorin, N(5)-Formyltetrahydrofolate, Wellcovorin
  • SMILES: C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]
  • InChl: InChI=1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12-,13-;/m0./s1
  • Product Description:

    Levoleucovorin Calcium is a levo isoform of leucovorin calcium with antineoplastic activity. Levoleucovorin is an active metabolite of folic acid, which does not require metabolism by dihydrofolate reductase. This agent counteracts the toxic effects of other folic acid derivative agents, rescuing the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service